Tech Company Financing Transactions

Alnara Pharmaceuticals Funding Round

Alnara Pharmaceuticals secured a $20 million Series A venture capital round on 10/30/2008. Investors included Frazier Healthcare Partners, Bessemer Venture Partners and Third Rock Ventures.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

840 Memorial Dr.
Cambridge, MA 02139
USA

Phone

(617) 349-3690

Website

www.alnara.com

Email Address

[email protected]

Overview

Alnara Pharmaceuticals Inc is a pharmaceutical company developing innovative non-systemic protein therapeutics for the treatment of metabolic and inflammatory diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Alexey Margolin

        

Chief Medical Officer

Lee Brettman

        

Vice President

Thomas Rowland

        

Vice President

Hugh Wight

        

Browse more venture capital transactions:

Prev: 10/30/2008: SolarCity venture capital transaction
Next: 10/31/2008: Evri venture capital transaction

Share this article

About Our VC Transactions Data

We report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary